The Role of Gold-Loaded Copper Oxide Nanoplates in the Formulation of Sensitive EC-SERS Substrates for the Detection of Anti-Cancer Drugs: Spectro–Electro and DFT Studies-Reference-Cited by-同舟云学术

The Role of Gold-Loaded Copper Oxide Nanoplates in the Formulation of Sensitive EC-SERS Substrates for the Detection of Anti-Cancer Drugs: Spectro–Electro and DFT Studies

Published:2023-10-31 Issue:1 Volume:49 Page:673-684
ISSN:2193-567X
Container-title:Arabian Journal for Science and Engineering
language:en
Short-container-title:Arab J Sci Eng

Author:

Haroon Muhammad,Al-Saadi Abdulaziz A.^ORCID

Funder

King Fahd University of Petroleum and Minerals

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://link.springer.com/content/pdf/10.1007/s13369-023-08384-6.pdf

Reference66 articles.

1. Teng, S.; Ma, C.; Yu, Y.; Yi, C.: Hydroxyurea promotes TET1 expression and induces apoptosis in osteosarcoma cells. Biosci. Rep. (2019). https://doi.org/10.1042/BSR20190456/219136

2. Teng, J.; Hejazi, S.; Hiddingh, L.; Carvalho, L.; De Gooijer, M.C.; Wakimoto, H.; Barazas, M.; Tannous, M.; Chi, A.S.; Noske, D.P.; Wesseling, P.; Wurdinger, T.; Batchelor, T.T.; Tannous, B.A.: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype. Neuro Oncol. 20, 642–654 (2018). https://doi.org/10.1093/NEUONC/NOX198

3. Angona, A.; Bellosillo, B.; Alvarez-Larrán, A.; Martínez-Avilés, L.; Camacho, L.; Pairet, S.; Fernández-Rodriguez, M.C.; Ancochea, À.; Besses, C.: Genetic predisposition to molecular response in patients with myeloproliferative neoplasms treated with hydroxycarbamide. Leuk. Res. 37, 917–921 (2013). https://doi.org/10.1016/J.LEUKRES.2013.03.013

4. Berthaut, I.; Bachir, D.; Kotti, S.; Chalas, C.; Stankovic, K.; Eustache, F.; Ravel, C.; Habibi, A.; Brailly-Tabard, S.; Lévy-Dutel, L.; Bleibtreu, A.; Simon, T.; Galactéros, F.; Lionnet, F.; Mandelbaum, J.: Adverse effect of hydroxyurea on spermatogenesis in patients with sickle cell anemia after 6 months of treatment. Blood 130, 2354–2356 (2017). https://doi.org/10.1182/BLOOD-2017-03-771857

5. Liebelt, E.L.; Balk, S.J.; Faber, W.; Fisher, J.W.; Hughes, C.L.; Lanzkron, S.M.; Lewis, K.M.; Marchetti, F.; Mehendale, H.M.; Rogers, J.M.; Shad, A.T.; Skalko, R.G.; Stanek, E.J.; Shelby, M.D.: NTP-CERHR expert panel report on the reproductive and developmental toxicity of hydroxyurea. Birth Defects Res. B Dev. Reprod. Toxicol. 80, 259–366 (2007). https://doi.org/10.1002/BDRB.20123